- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2025 | 2.51M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.9M sh |
| Capex | FY 2024 · Dec 31, 2023 | $194K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$3.43M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $549K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $10.21M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $12.07M |
| Current Assets | FY 2024 · Dec 31, 2023 | $21.99M |
| Total Assets | FY 2024 · Dec 31, 2023 | $25.26M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$3.45 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$3.45 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $4.29M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $1.22M |
| Net Income | FY 2024 · Dec 31, 2023 | −$6.55M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$5.99M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $695K |
| Revenue | FY 2024 · Dec 31, 2023 | $15.29M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $18.18M |